# Aurinia Pharmaceuticals Inc.: Form SCHEDULE 13D/A, filed Aug 26, 2026

- Company: [Aurinia Pharmaceuticals Inc.](/companies/auph.md) (CIK 1600620)
- Form: SCHEDULE 13D/A
- Filed: 2026-08-26
- Accepted by EDGAR: Aug 26, 2026, 21:24 ET
- Period: not reported
- Accession: 0001104659-26-101785
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1600620/000110465926101785/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1600620/000110465926101785/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1600620/000110465926101785/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Aug 26, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-101785. Last ingested by Listed: Oct 30, 2026, 08:08 ET. No prices; not investment advice.